Print

Purpose

The purpose of this research is to determine the feasibility of a new supportive intervention, called Pathways, for patients with metastatic lung cancer.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • new or recurrent AJCC stage IV non-small cell lung cancer
  • 18 years of age or older
  • ECOG PS 0-2/Karnofsky 60-100
  • 3 to 12 weeks into active cancer treatment

Exclusion Criteria

  • unstable brain metastases
  • cognitive or psychiatric condition for which participating would be inappropriate
  • unable to speak and read English

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Supportive Care
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Pathways
Pathways is designed to help patients identify and pursue values-based goals and address potential goal obstacles, including lung cancer stigma.
  • Behavioral: Pathways
    Goal-setting intervention to help patients identify personal values, value-consistent goals, and ways to pursue goals and address goal obstacles. Although potential refinements may occur based on aim 1 (refining procedures and content with 6 patients), Pathways is designed to consist primarily of 2 in-person sessions (~30-60 minutes) delivered when patients are in clinic for cancer treatment, with supporting phone calls and contact in between sessions.

Recruiting Locations

UK Center for Clinical and Translational Science and nearby locations

University of Kentucky
Lexington, Kentucky 40506
Contact:
Laurie McLouth

More Details

NCT ID
NCT04161157
Status
Recruiting
Sponsor
Laurie McLouth

Study Contact

Laurie McLouth, PhD
859-562-2526
laurie.mclouth@uky.edu

Detailed Description

In this study, investigators will first test the Pathways procedures with 6 patients to identify any improvements that need to be made. Then, investigators will test the feasibility of the Pathways intervention with 20 patients who are undergoing cancer treatment for metastatic lung cancer. Pathways is designed to help patients set and pursue personal goals during lung cancer treatment. In this study, investigators want to see if they can recruit patients with lung cancer who are being treated at the University of Kentucky Markey Cancer Center to participate in the Pathways intervention.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.